Topical thrombin and acquired coagulation factor inhibitors: Clinical spectrum and laboratory diagnosis

Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens

1957 • 3,280 citations

Hematology: Basic Principles and Practice

1991 • 1,907 citations

Acquired inhibitors of blood coagulation.

1972 • 531 citations

A More Uniform Measurement of Factor VIII Inhibitors

1975 • 316 citations

Anti-prothrombin antibodies and the lupus anticoagulant

1988 • 255 citations

A mechanism for the hypoprothrombinemia of the acquired hypoprothrombinemia-lupus anticoagulant syndrome

1983 • 214 citations

Development of antibodies to thrombin and factor V with recurrent bleeding in a patient exposed to topical bovine thrombin

1990 • 186 citations

Development of antibodies to thrombin and factor V with recurrent bleeding in a patient exposed to topical bovine thrombin

1990 • 182 citations

Fibrin seal: The state of the art

1985 • 178 citations

Isolation and study of an acquired inhibitor of human coagulation factor V.

1986 • 172 citations

Clinical Significance of Antibodies to Bovine and Human Thrombin and Factor V After Surgical Use of Bovine Thrombin

1992 • 132 citations

Fibrin glue

1991 • 132 citations

Successful management of bleeding in a patient with factor V inhibitor by platelet transfusions

1980 • 112 citations

Redo cardiac surgery: late bleeding complications from topical thrombin-induced factor V deficiency.

1993 • 91 citations

Immunization by bovine thrombin used with fibrin glue during cardiovascular operations. Development of thrombin and factor V inhibitors.

1993 • 91 citations

Iatrogenic Immunization with Bovine Thrombin: A Mechanism for Prolonged Thrombin Times after Surgery

1989 • 90 citations

Immunization by bovine thrombin used with fibrin glue during cardiovascular operations

1993 • 85 citations

Development of antithrombin antibodies following surgery in patients with prosthetic cardiac valves [see comments]

1988 • 80 citations

Redo cardiac surgery: Late bleeding complications from topical thrombin-induced factor V deficiency

1993 • 78 citations

CD66 identifies a neutrophil-specific epitope within the hematopoietic system that is expressed by members of the carcinoembryonic antigen family of adhesion molecules

1991 • 70 citations

Bovine thrombin-induced inhibitor of factor V and bleeding risk in postoperative neurosurgical patients

1993 • 70 citations

Hemorrhagic death associated with a high titer factor V inhibitor

1978 • 61 citations

Topical thrombin-induced IgE-mediated anaphylaxis: RAST analysis and skin test studies

1991 • 54 citations

Isolation and characterization of an acquired antithrombin antibody

1990 • 41 citations

Isolation and characterization of an acquired antithrombin antibody

1990 • 39 citations

Partial Characterization of an Autoantibody Recognizing the Secondary Binding Site(s) of Thrombin in a Patient with Recurrent Spontaneous Arterial Thrombosis

1992 • 25 citations

An acquired antithrombin autoantibody directed toward the catalytic center of the enzyme.

1991 • 24 citations

DEVELOPMENT OF ANTI‐BOVINE THROMBIN ANTIBODIES FOLLOWING NEUROSURGICAL PROCEDURES

1990 • 20 citations

Antibodies to thrombin in postsurgical patients [letter; comment]

1989 • 17 citations